Recursion and Exscientia merge to form drug discovery company
Recursion has signed an agreement to merge with Exscientia to create a global technology-enabled drug discovery company.
Recursion has signed an agreement to merge with Exscientia to create a global technology-enabled drug discovery company.
What's Your Reaction?
